12 results for author:"Deinum J." in Literature citations
Results Customize
› Repeat search in UniProtKB (2)
| Neurocognitive function in dopamine-beta-hydroxylase deficiency. Jepma M., Deinum J., Asplund C.L., Rombouts S.A., Tamsma J.T., Tjeerdema N., Spape M.M., Garland E.M., Robertson D., Lenders J.W. et al. Neuropsychopharmacology 36:1608-1619(2011) · Mapped (1) |
| gamma-Adducin stimulates the thiazide-sensitive NaCl cotransporter. Dimke H., San-Cristobal P., de Graaf M., Lenders J.W., Deinum J., Hoenderop J.G., Bindels R.J. J. Am. Soc. Nephrol. 22:508-517(2011) · Mapped (4) |
| Clavatadine A, a natural product with selective recognition and irreversible inhibition of factor XIa. Buchanan M.S., Carroll A.R., Wessling D., Jobling M., Avery V.M., Davis R.A., Feng Y., Xue Y., Oster L., Fex T. et al. J. Med. Chem. 51:3583-3587(2008) · Mapped (1) |
| Heterogeneous glycosylation patterns of human PAI-1 may reveal its cellular origin. Brogren H., Sihlbom C., Wallmark K., Lonn M., Deinum J., Karlsson L., Jern S. Thromb. Res. 122:271-281(2008) · Mapped (4) |
| Discovery of a novel warhead against beta-secretase through fragment-based lead generation. Geschwindner S., Olsson L.L., Albert J.S., Deinum J., Edwards P.D., de Beer T., Folmer R.H. J. Med. Chem. 50:5903-5911(2007) · Mapped (1) |
| Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. Zhu C., Wang X., Deinum J., Huang Z., Gao J., Modjtahedi N., Neagu M.R., Nilsson M., Eriksson P.S., Hagberg H. et al. J. Exp. Med. 204:1741-1748(2007) · Mapped (4) |
| An IGF-I gene polymorphism modifies the risk of developing persistent microalbuminuria in type 1 diabetes. Hovind P., Lamberts S., Hop W., Deinum J., Tarnow L., Parving H.H., Janssen J.A. Eur. J. Endocrinol. 156:83-90(2007) · Mapped (7) |
| Biochemical importance of glycosylation of plasminogen activator inhibitor-1. Gils A., Pedersen K.E., Skottrup P., Christensen A., Naessens D., Deinum J., Enghild J.J., Declerck P.J., Andreasen P.A. Thromb. Haemost. 90:206-217(2003) · Mapped (4) |
| Polymorphism in the promoter region of the insulin-like growth factor I gene is related to carotid intima-media thickness and aortic pulse wave velocity in subjects with hypertension. Schut A.F., Janssen J.A., Deinum J., Vergeer J.M., Hofman A., Lamberts S.W., Oostra B.A., Pols H.A., Witteman J.C., van Duijn C.M. Stroke 34:1623-1627(2003) · Mapped (7) |
| Point mutation in the stalk of angiotensin-converting enzyme causes a dramatic increase in serum angiotensin-converting enzyme but no cardiovascular disease. Kramers C., Danilov S.M., Deinum J., Balyasnikova I.V., Scharenborg N., Looman M., Boomsma F., de Keijzer M.H., van Duijn C., Martin S. et al. Circulation 104:1236-1240(2001) · UniProtKB (1) |
| Increased shedding of angiotensin-converting enzyme by a mutation identified in the stalk region. Eyries M., Michaud A., Deinum J., Agrapart M., Chomilier J., Kramers C., Soubrier F. J. Biol. Chem. 276:5525-5532(2001) · UniProtKB (1) |
| Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide. Xue Y., Bjoerquist P., Inghardt T., Linschoten M., Musil D., Sjoelin L., Deinum J. Structure 6:627-636(1998) · UniProtKB (1) |